PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1892095
PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1892095
Emerging Tools Reshaping the Future of Gene Editing
This study highlights advancements such as prime editing, base editing, bridge RNA, SeekRNA, and gene writing platforms, as it examines the emerging field of next-generation gene editing technologies beyond CRISPR/Cas systems. These tools are revolutionary for therapeutic development, precision medicine, and functional genomics because they provide increased editing capabilities, decreased off-target effects, and improved precision. To improve accuracy and efficiency in genome engineering, the study highlights the use of artificial intelligence (AI) and machine learning for guide RNA optimization, off-target prediction, and scalable clinical translation. The collaborative innovation ecosystem is mapped by examining key stakeholders, including academic consortia, large pharmaceutical companies, biotech start-ups, and companies that provide AI-driven editing solutions. Additionally, to evaluate commercialization readiness, global funding trends, investment patterns, and regulatory environments in North America, Europe, Asia-Pacific, and emerging regions are examined. The study highlights how disruptive tools are changing the future of genetic medicine and biotechnology by spotting growth prospects and strategic partnerships.